Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression
申请人:Klinge Pharma GmbH
公开号:US06451816B1
公开(公告)日:2002-09-17
The invention relates to the use of pharmacologically valuable pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides according to general formula (I) in the treatment of tumors or for immunosuppression.
该发明涉及根据通式(I)中的具有药理学价值的吡啶基烷、吡啶基烯和/或吡啶基炔酸酰胺在肿瘤治疗或免疫抑制中的使用。